CN1665535A - 和免疫治疗剂联合使用的苝醌 - Google Patents

和免疫治疗剂联合使用的苝醌 Download PDF

Info

Publication number
CN1665535A
CN1665535A CN028066456A CN02806645A CN1665535A CN 1665535 A CN1665535 A CN 1665535A CN 028066456 A CN028066456 A CN 028066456A CN 02806645 A CN02806645 A CN 02806645A CN 1665535 A CN1665535 A CN 1665535A
Authority
CN
China
Prior art keywords
tumor
hypocrellin
cell
hypocretin
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN028066456A
Other languages
English (en)
Chinese (zh)
Inventor
比亚特丽斯·勒弗格勒
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Quest Pharmatech Inc
Original Assignee
Altachem Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altachem Pharma Ltd filed Critical Altachem Pharma Ltd
Publication of CN1665535A publication Critical patent/CN1665535A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CN028066456A 2001-01-30 2002-01-29 和免疫治疗剂联合使用的苝醌 Pending CN1665535A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26467701P 2001-01-30 2001-01-30
US60/264,677 2001-01-30

Publications (1)

Publication Number Publication Date
CN1665535A true CN1665535A (zh) 2005-09-07

Family

ID=23007123

Family Applications (1)

Application Number Title Priority Date Filing Date
CN028066456A Pending CN1665535A (zh) 2001-01-30 2002-01-29 和免疫治疗剂联合使用的苝醌

Country Status (9)

Country Link
US (1) US20040110846A1 (enExample)
EP (1) EP1357944B1 (enExample)
JP (1) JP2004529091A (enExample)
CN (1) CN1665535A (enExample)
AT (1) ATE364398T1 (enExample)
AU (1) AU2002234809B2 (enExample)
CA (1) CA2436233C (enExample)
DE (1) DE60220642T2 (enExample)
WO (1) WO2002060482A2 (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102138640A (zh) * 2011-01-14 2011-08-03 江南大学 苝醌化合物在制备防治禽类病毒饲料中的应用
CN109456210A (zh) * 2017-09-06 2019-03-12 中国科学院理化技术研究所 一种竹红菌素迫位和2-位同时氨基取代的衍生物及其制备方法和应用
CN114007649A (zh) * 2019-03-29 2022-02-01 布里格姆及妇女医院股份有限公司 靶向协同癌症免疫疗法

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1349965A (zh) * 2000-10-25 2002-05-22 中国科学院感光化学研究所 带有脂肪环或芳香环的脂肪胺基取代去甲氧基竹红菌素及其合成方法和用途
US6627664B2 (en) * 2001-01-30 2003-09-30 Altachem Pharma Ltd. Perylenequinones for use as sonosensitizers
JP2007513184A (ja) 2003-12-04 2007-05-24 バーテックス　ファーマシューティカルズ　インコーポレイテッド プロテインキナーゼのインヒビターとして有用なキノキサリン
JP5205264B2 (ja) 2005-08-10 2013-06-05 クウェスト・ファーマテック・インコーポレイテッド ペリレンキノン誘導体及びその使用
US8454991B2 (en) * 2006-07-24 2013-06-04 Quest Pharmatech Inc. Method and device for photodynamic therapy
CN109453408A (zh) * 2018-11-16 2019-03-12 江南大学 抗菌创伤敷料及其制备方法
CN115282133A (zh) * 2021-12-06 2022-11-04 温州医科大学 竹红菌乙素在制备抗结肠癌药物中的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1015033A4 (en) * 1997-01-10 2000-07-05 Altarex Inc SUBSTITUTED PERYLENEQUINONES FOR USE IN PHOTODYNAMIC THERAPY
GB9710049D0 (en) * 1997-05-19 1997-07-09 Nycomed Imaging As Method
AU757175B2 (en) * 1997-09-05 2003-02-06 Regents Of The University Of California, The Use of immunostimulatory oligonucleotides for preventing or reducing antigen-stimulated, granulocyte-mediated inflammation
EP1820514A3 (en) * 1998-06-15 2007-10-17 AltaRex Medical Corporation Therapeutic compositions that produce an immune response by altering the antigen
US20020022032A1 (en) * 1999-04-23 2002-02-21 Curry Patrick Mark Immuno-adjuvant PDT treatment of metastatic tumors
ATE290879T1 (de) * 1999-08-18 2005-04-15 Altarex Medical Corp Therapeutische antikörper gegen das muc-1 antigen und verfahren zu deren verwendung
ES2254408T4 (es) * 2000-04-25 2007-10-01 Immunex Corporation Procedimiento de tratamiento de tumores usando terapia fotodinamica.
US6627664B2 (en) * 2001-01-30 2003-09-30 Altachem Pharma Ltd. Perylenequinones for use as sonosensitizers
ATE554763T1 (de) * 2001-02-06 2012-05-15 Quadra Logic Tech Inc Photodynamische therapie der mit der altersbezogenen makuladegeneration verbundenen okkulten chorioidalen neovaskularisation

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102138640A (zh) * 2011-01-14 2011-08-03 江南大学 苝醌化合物在制备防治禽类病毒饲料中的应用
CN109456210A (zh) * 2017-09-06 2019-03-12 中国科学院理化技术研究所 一种竹红菌素迫位和2-位同时氨基取代的衍生物及其制备方法和应用
CN114007649A (zh) * 2019-03-29 2022-02-01 布里格姆及妇女医院股份有限公司 靶向协同癌症免疫疗法

Also Published As

Publication number Publication date
CA2436233C (en) 2010-10-05
US20040110846A1 (en) 2004-06-10
JP2004529091A (ja) 2004-09-24
CA2436233A1 (en) 2002-08-08
ATE364398T1 (de) 2007-07-15
WO2002060482A2 (en) 2002-08-08
EP1357944A2 (en) 2003-11-05
DE60220642T2 (de) 2008-02-21
DE60220642D1 (de) 2007-07-26
EP1357944B1 (en) 2007-06-13
AU2002234809B2 (en) 2005-04-07
WO2002060482A3 (en) 2003-02-13

Similar Documents

Publication Publication Date Title
CN1894003A (zh) 用于局部脂肪细胞减少的光动力疗法
CN1222309C (zh) 将分子导入细胞溶质
Ortel et al. Molecular mechanisms of photodynamic therapy
Dougherty et al. Photodynamic therapy
US6899723B2 (en) Transcutaneous photodynamic treatment of targeted cells
KR20000035893A (ko) 분자 제제 광-활성화의 선택성 개선 방법
Korbelik Cancer vaccines generated by photodynamic therapy
CN1160356A (zh) 使血中细胞选择性失活和治疗免疫失调疾病的光动力疗法
US8383836B2 (en) Methods and systems for treating cell proliferation disorders with psoralen derivatives
CN1665535A (zh) 和免疫治疗剂联合使用的苝醌
WO2001015694A1 (en) Extended duration light activated cancer therapy
JP2003508124A5 (enExample)
CN1254339A (zh) 作为光活性剂的一氢苯并卟啉衍生物的乙二醇酯
CN1802186A (zh) 光力学治疗装置、光力学治疗装置的控制方法及光力学治疗方法
Beissert et al. Role of immunomodulation in diseases responsive to phototherapy
CN1531442A (zh) 用作光敏剂和声敏剂的苝醌
AU2002234809A1 (en) Perylenequinones for use with immunotherapy agents
Ma et al. Combination sonodynamic therapy with immunoadjuvant may be a promising new modality for cancer treatment
Katete et al. Photodynamic therapy for the diagnosis and treatment of cancer
Sliakhtsin et al. 17 INVESTIGATION OF TISSUE BIODISTRIBUTION AND PLASMA PHARMACOKINETICS OF PHOTOLON®/FOTOLON® IN INTACT AND TUMOR-BEARING RATS. EVALUATION OF THE ABILITY OF THE PHOTOSENSITIZER TO PASS THROUGH INTACT HISTOHEMATOGENOUS BARRIERS
Korbelik Advances in the understanding of host response associated with tumor PDT
HK1065709A (en) Perylenequinones for use as photosensitizers and sonosensitizers
CN1371749A (zh) 一种来源于动物中药的生物治疗佐剂
Shams Split-dose photodynamic therapy: Optimizing cures while preventing disseminated tumors
HK1004110B (en) Transfer of molecules into the cytosol of cells

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
ASS Succession or assignment of patent right

Free format text: FORMER OWNER: PIETE LISHILEFUGELE

Effective date: 20050812

C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20050812

Address after: Alberta Canada

Applicant after: Altachemfarma Co., Ltd.

Address before: Alberta Canada

Applicant before: Altachemfarma Co., Ltd.

Co-applicant before: Leveugle Beatrice

C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20050907